Literature DB >> 2872483

Lithium for painful dystonia in Parkinson's disease.

N Quinn, C D Marsden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2872483     DOI： 10.1016/s0140-6736(86)91681-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Pharmacological treatment of Parkinson's disease.

Authors:  A Münchau; K P Bhatia
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 2.  Dystonia in Parkinson's disease.

Authors:  Eduardo Tolosa; Yaroslau Compta
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

3.  Lithium down-regulates histone deacetylase 1 (HDAC1) and induces degradation of mutant huntingtin.

Authors:  Shuai Wu; Shui-Di Zheng; Hong-Ling Huang; Li-Chong Yan; Xiao-Fei Yin; Hai-Neng Xu; Kang-Jian Zhang; Jing-Hua Gui; Liang Chu; Xin-Yuan Liu
Journal:  J Biol Chem       Date:  2013-10-28       Impact factor: 5.157
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.